151 related articles for article (PubMed ID: 9638104)
1. Finasteride for BPH.
Johnson KH; Casey CM
J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
[No Abstract] [Full Text] [Related]
2. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
[TBL] [Abstract][Full Text] [Related]
3. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
[TBL] [Abstract][Full Text] [Related]
4. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
5. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
[No Abstract] [Full Text] [Related]
6. Terazosin vs finasteride for BPH.
Zacks M
J Fam Pract; 1996 Dec; 43(6):533. PubMed ID: 8969692
[No Abstract] [Full Text] [Related]
7. When you just can't go: my patient, a 63-year old stockbroker, recalled his experience with acute urinary retention.
Consum Rep; 2009 Aug; 74(8):19. PubMed ID: 19821541
[No Abstract] [Full Text] [Related]
8. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
Fenter TC; Davis EA; Shah MB; Lin PJ
Am J Manag Care; 2008 May; 14(5 Suppl 2):S154-9. PubMed ID: 18611089
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
Marberger MJ
Urology; 1998 May; 51(5):677-86. PubMed ID: 9610579
[TBL] [Abstract][Full Text] [Related]
10. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.
Boyle P; Roehrborn C; Harkaway R; Logie J; de la Rosette J; Emberton M
Eur Urol; 2004 May; 45(5):620-6; discussion 626-7. PubMed ID: 15082205
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
Collins GN
BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
[No Abstract] [Full Text] [Related]
12. Finasteride to prevent morbidity from benign prostatic hyperplasia.
Wasson JH
N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770
[No Abstract] [Full Text] [Related]
13. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
14. Benign prostatic hyperplasia.
Kirby R
BMJ; 1999 Feb; 318(7180):343-4. PubMed ID: 9933175
[No Abstract] [Full Text] [Related]
15. [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia].
de la Taille A
Prog Urol; 2008 Apr; 18 Suppl 3():S53-7. PubMed ID: 18455085
[TBL] [Abstract][Full Text] [Related]
16. Questions whether clients were properly informed about treatment protocol.
Koltveit AJ
J Am Vet Med Assoc; 2001 Jun; 218(11):1721-2. PubMed ID: 11394816
[No Abstract] [Full Text] [Related]
17. Benign prostatic hypertrophy: update on drug therapy.
Tejani A; Musini V; Perry TL; Mintzes B; Wright JM
Can Fam Physician; 2006 Sep; 52(9):1075-6, 1077-8. PubMed ID: 17279217
[No Abstract] [Full Text] [Related]
18. Finasteride in benign prostatic hyperplasia.
Wysowski DK; Farinas E
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
[No Abstract] [Full Text] [Related]
19. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
Magoha GA
East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
Loran OB; Pushkar' DIu; Rasner PI
Urologiia; 2002; (1):19-22. PubMed ID: 11877966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]